Y
Yoshiko Oshiro
Researcher at University of Tsukuba
Publications - 62
Citations - 1328
Yoshiko Oshiro is an academic researcher from University of Tsukuba. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 20, co-authored 55 publications receiving 1101 citations.
Papers
More filters
Journal ArticleDOI
Proton Beam Therapy for Hepatocellular Carcinoma: A Comparison of Three Treatment Protocols
Masashi Mizumoto,Toshiyuki Okumura,Takayuki Hashimoto,Kuniaki Fukuda,Yoshiko Oshiro,Nobuyoshi Fukumitsu,Masato Abei,Atsushi Kawaguchi,Yasutaka Hayashi,Ayako Ookawa,Haruko Hashii,Ayae Kanemoto,Takashi Moritake,Eriko Tohno,Koji Tsuboi,Takeji Sakae,Hideyuki Sakurai +16 more
TL;DR: This study showed that proton beam therapy achieved good local control for HCC using each of three treatment protocols, suggesting that selection of treatment schedules based on tumor location may be used to reduce the risk of late toxicity and maintain good treatment efficacy.
Journal ArticleDOI
Proton Beam Therapy for Large Hepatocellular Carcinoma
Shinji Sugahara,Yoshiko Oshiro,Hidetsugu Nakayama,Kltniaki Fukuda,Masashi Mizumoto,Masato Abei,Junichi Shoda,Yasushi Matsuzaki,Eriko Thono,Mari Tokita,Koji Tsuboi,Koichi Tokuuye +11 more
TL;DR: This study shows that PBT is an effective and safe method for the treatment of patients with large HCC because the Bragg peak properties of PBT allow for improved conformality of the treatment field.
Journal ArticleDOI
Phase I/II Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme
Masashi Mizumoto,Koji Tsuboi,Hiroshi Igaki,Takashi Yamamoto,Shingo Takano,Yoshiko Oshiro,Yasutaka Hayashi,Haruko Hashii,Ayae Kanemoto,Hidetsugu Nakayama,Shinji Sugahara,Hideyuki Sakurai,Akira Matsumura,Koichi Tokuuye +13 more
TL;DR: Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme was tolerable and beneficial if the target size was well considered and the possibility of controlling border region recurrences was pursued.
Journal ArticleDOI
Role of Radiotherapy for Local Control of Asymptomatic Adrenal Metastasis From Lung Cancer
TL;DR: It is suggested that radiotherapy is a treatment option that can be used in addition to surgical resection and contribute to survival of patients with adrenal metastasis from lung cancer.
Journal ArticleDOI
Stereotactic Body Radiotherapy for Lung Tumors at the Pulmonary Hilum
TL;DR: SBRT for lung tumors located in the pulmonary hilar region may be tolerable and acceptable, if multiple treatments to the same major bronchus are avoided, and irradiated volumes are carefully taken into consideration.